We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
-0.72%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+386.48%
AUM
$16.7B
AUM Growth
-$332M
Cap. Flow
-$57.8M
Cap. Flow %
-0.35%
Top 10 Hldgs %
17.41%
Holding
2,287
New
114
Increased
795
Reduced
1,162
Closed
171
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NCA icon
601
Nuveen California Municipal Value Fund
NCA
$302M
$5.73M 0.03%
543,522
+61,277
+13% +$656K
EXAS
602
DELISTED
Exact Sciences
EXAS
$5.73M 0.03%
59,994
+4,069
+7% +$430K
TAP icon
603
Molson Coors Class B
TAP
$8.09B
$5.7M 0.03%
122,889
-38,770
-24% -$1.89M
CHKP icon
604
Check Point Software Technologies
CHKP
$13.1B
$5.68M 0.03%
50,249
-9,005
-15% -$1.1M
PARA
605
DELISTED
Paramount Global Class B
PARA
$5.66M 0.03%
143,350
-52,932
-27% -$2.16M
TRNO icon
606
Terreno Realty
TRNO
$7.49B
$5.65M 0.03%
89,330
-126,700
-59% -$8.43M
MHN
607
DELISTED
BlackRock MuniHoldings New Yrok Quality Fund
MHN
$5.64M 0.03%
388,050
+30,227
+8% +$449K
TRMB icon
608
Trimble
TRMB
$13.9B
$5.64M 0.03%
68,600
+33,975
+98% +$2.98M
ENPH icon
609
Enphase Energy
ENPH
$5.53B
$5.64M 0.03%
37,611
+8,236
+28% +$1.41M
PBCT
610
DELISTED
People's United Financial Inc
PBCT
$5.64M 0.03%
322,786
-49,514
-13% -$805K
ZTS icon
611
Zoetis
ZTS
$30B
$5.64M 0.03%
29,035
-263
-0.9% -$53.1K
NBIX icon
612
Neurocrine Biosciences
NBIX
$16.6B
$5.63M 0.03%
58,733
-1,322
-2% -$125K
NRK icon
613
Nuveen New York AMT-Free Quality Municipal Income Fund
NRK
$912M
$5.63M 0.03%
406,989
+30,633
+8% +$434K
WAT icon
614
Waters Corp
WAT
$39.9B
$5.6M 0.03%
15,669
+3,372
+27% +$1.32M
PZC
615
DELISTED
PIMCO California Municipal Income Fund III
PZC
$5.58M 0.03%
506,872
+17,991
+4% +$204K
MYN icon
616
BlackRock MuniYield New York Quality Fund
MYN
$377M
$5.56M 0.03%
403,327
+31,436
+8% +$451K
MTTRW
617
DELISTED
Matterport, Inc. Warrant
MTTRW
$5.56M 0.03%
714,361
KIO
618
KKR Income Opportunities Fund
KIO
$457M
$5.55M 0.03%
339,046
-20,700
-6% -$340K
KTF
619
DWS Municipal Income Trust
KTF
$352M
$5.55M 0.03%
466,115
+86,675
+23% +$1.06M
GRMN
620
Garmin
GRMN
$60B
$5.54M 0.03%
35,634
-10,368
-23% -$1.69M
KSU
621
DELISTED
Kansas City Southern
KSU
$5.51M 0.03%
20,344
-4,912
-19% -$1.37M
AXS icon
622
AXIS Capital
AXS
$7.55B
$5.5M 0.03%
119,567
-67,407
-36% -$3.34M
AEIS icon
623
Advanced Energy
AEIS
$13B
$5.5M 0.03%
62,657
+54,918
+710% +$5.14M
MKC icon
624
McCormick & Company Non-Voting
MKC
$14.2B
$5.48M 0.03%
67,669
-3,514
-5% -$302K
CMC icon
625
Commercial Metals
CMC
$8.31B
$5.46M 0.03%
179,121
-191,758
-52% -$6.11M

Similar funds

Guggenheim Capital's Q3 2021 Portfolio in Review

As of Q3 2021, Guggenheim Capital held 2,287 positions worth $16.7B, down 2% from $17B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Guggenheim Capital's Q3 2021 filing shows 114 new, 795 increased, 1,162 reduced and 171 closed positions. Its largest new stake was Logistics Innovation Technologies Corp. Class A Common Stock: 4,000,000 shares worth $38.6M. The largest sale was Alexion Pharmaceuticals, an estimated $41.8M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

  • Guggenheim Capital's largest Q3 2021 buy was Logistics Innovation Technologies Corp. Class A Common Stock: 4,000,000 shares worth $38.6M.
  • Guggenheim Capital added most to iShares Core US Aggregate Bond ETF in Q3 2021, an estimated $50M increase.
  • Guggenheim Capital's biggest Q3 2021 reduction was Matterport, Inc. Class A Common Stock, cutting an estimated $32.4M.
  • Guggenheim Capital fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $41.8M.
  • Guggenheim Capital's ten largest holdings make up 17% of its $16.7B portfolio in Q3 2021.
  • Guggenheim Capital opened 114 new positions and closed 171 in Q3 2021.
  • Guggenheim Capital's portfolio value fell 2% quarter-over-quarter to $16.7B.

Based on Guggenheim Capital's 13F filing for Q3 2021, filed 15 Nov 2021.